NYSE: LNG
Cheniere Energy, Inc.CIK 0000003570 · SIC 4924 · Natural Gas Distribution
Every 8-K is open in full. Other 10-Ks and 10-Qs show a 3-bullet preview. A free account reads 3 more full reports a month. Generating a report requires a verified account.
Sign up freeWant to see a complete report first? Today's free report (GIS 10-Q) is open in full — no account needed.
Cheniere Energy registers $1.75B of notes in exchange offer; no new capital raised
6 material changes detected. Sign up free to read the summary.
Summary not yet generated.
Partner
Trade LNG commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Cheniere Q2 net income jumps 89% to $3.07B, but H1 swings to $434M loss on derivatives
5 material changes detected. Sign up free to read the summary.
Summary not yet generated.
Summary not yet generated.
Summary not yet generated.
Summary not yet generated.
Summary not yet generated.
Summary not yet generated.
Summary not yet generated.
Summary not yet generated.
Summary not yet generated.
Summary not yet generated.
Summary not yet generated.
Latest financial statements
From 10-Q filed Aug 6, 2026 (period ending Jun 30, 2026). As printed on the EDGAR/iXBRL face — not generated by the model.
Consolidated Statements of Operations (Unaudited)
(in millions, except per share data)
| Description | Three months ended June 30, 2026 | Three months ended June 30, 2025 | Six months ended June 30, 2026 | Six months ended June 30, 2025 |
|---|---|---|---|---|
| Revenues | ||||
| LNG revenues | 5,640 | 4,515 | 11,362 | 9,820 |
| Regasification revenues | 34 | 34 | 68 | 68 |
| Other revenues | 58 | 92 | 170 | 197 |
| Total revenues | 5,732 | 4,641 | 11,600 | 10,085 |
| Operating costs and expenses | ||||
| Cost of sales (excluding operating and maintenance expense and depreciation, amortization and accretion expense shown separately below) | 439 | 1,117 | 8,757 | 4,688 |
| Operating and maintenance expense | 533 | 559 | 1,058 | 1,032 |
| Selling, general and administrative expense | 88 | 99 | 224 | 215 |
| Depreciation, amortization and accretion expense | 380 | 329 | 753 | 641 |
| Other operating costs and expenses | 2 | 7 | 6 | 18 |
| Total operating costs and expenses | 1,442 | 2,111 | 10,798 | 6,594 |
| Income from operations | 4,290 | 2,530 | 802 | 3,491 |
| Other income (expense) | ||||
| Interest expense, net of capitalized interest | (287) | (237) | (542) | (466) |
| Interest and dividend income | 19 | 31 | 35 | 68 |
| Other income (expense), net | (14) | (1) | (40) | 19 |
| Total other expense | (282) | (207) | (547) | (379) |
| Income before income taxes and NCI | 4,008 | 2,323 | 255 | 3,112 |
| Less: income tax provision | 366 | 426 | 25 | 547 |
| Net income | 3,642 | 1,897 | 230 | 2,565 |
| Less: net income attributable to NCI | 574 | 271 | 664 | 586 |
| Net income (loss) attributable to Cheniere | 3,068 | 1,626 | (434) | 1,979 |
| Net income (loss) per share attributable to common stockholders—basic (1) | 14.68 | 7.32 | (2.08) | 8.87 |
| Net income (loss) per share attributable to common stockholders—diluted (1) | 14.65 | 7.30 | (2.08) | 8.85 |
| Weighted average number of common shares outstanding—basic | 209.0 | 221.8 | 209.7 | 222.6 |
| Weighted average number of common shares outstanding—diluted | 209.5 | 222.3 | 209.7 | 223.2 |
| ___________________ | ||||
Consolidated Balance Sheets (Unaudited)
(in millions, except share data)
| Description | June 30, 2026 | December 31, 2025 |
|---|---|---|
| ASSETS | ||
| Current assets | ||
| Cash and cash equivalents | 1,099 | 1,099 |
| Restricted cash and cash equivalents | 420 | 485 |
| Trade and other receivables, net of current expected credit losses | 1,335 | 1,380 |
| Inventory | 723 | 524 |
| Current derivative assets | 156 | 9 |
| Margin deposits | 126 | 76 |
| Prepaid expenses | 117 | 72 |
| Other current assets, net | 136 | 47 |
| Total current assets | 4,112 | 3,692 |
| Property, plant and equipment, net of accumulated depreciation | 37,154 | 35,755 |
| Operating lease assets | 2,516 | 2,700 |
| Deferred NPNS assets | 2,195 | — |
| Derivative assets | 735 | 4,663 |
| Other non-current assets, net | 1,260 | 1,072 |
| Total assets | 47,972 | 47,882 |
| LIABILITIES, REDEEMABLE NCI AND STOCKHOLDERS’ EQUITY | ||
| Current liabilities | ||
| Accounts payable | 293 | 123 |
| Accrued liabilities | 1,676 | 2,081 |
| Current debt, net of unamortized discount and debt issuance costs | 1,411 | 306 |
| Deferred revenue | 116 | 150 |
| Current operating lease liabilities | 562 | 539 |
| Current portion of deferred NPNS liabilities | 166 | — |
| Current derivative liabilities | 377 | 618 |
| Other current liabilities | 122 | 99 |
| Total current liabilities | 4,723 | 3,916 |
| Long-term debt, net of unamortized discount and debt issuance costs | 22,632 | 22,507 |
| Operating lease liabilities | 1,951 | 2,163 |
| Deferred NPNS liabilities | 1,740 | — |
| Derivative liabilities | 301 | 1,208 |
| Deferred tax liabilities | 3,629 | 3,698 |
| Other non-current liabilities | 1,506 | 1,312 |
| Total liabilities | 36,482 | 34,804 |
| Redeemable NCI | — | 136 |
| Stockholders’ equity | ||
| Preferred stock: $0.0001 par value, 5.0 million shares authorized, none issued | — | — |
| Common stock: $0.003 par value, 480.0 million shares authorized; 279.6 million shares and 279.2 million shares issued at June 30, 2026 and December 31, 2025, respectively | 1 | 1 |
| Treasury stock: 71.7 million shares and 66.8 million shares at June 30, 2026 and December 31, 2025, respectively, at cost | (9,949) | (8,852) |
| Additional paid-in-capital | 4,566 | 4,523 |
| Retained earnings | 11,573 | 12,243 |
| Total Cheniere stockholders’ equity | 6,191 | 7,915 |
| NCI | 5,299 | 5,027 |
| Total stockholders’ equity | 11,490 | 12,942 |
| Total liabilities, redeemable NCI and stockholders’ equity | 47,972 | 47,882 |
Consolidated Statements of Cash Flows (Unaudited)
(in millions)
| Description | Six months ended June 30, 2026 | Six months ended June 30, 2025 |
|---|---|---|
| Cash flows from operating activities | ||
| Net income | 230 | 2,565 |
| Adjustments to reconcile net income to net cash provided by operating activities: | ||
| Depreciation, amortization and accretion expense | 753 | 641 |
| Share-based compensation expense | 115 | 105 |
| Amortization of discount and debt issuance costs | 20 | 19 |
| Reduction of right-of-use assets | 277 | 310 |
| Total losses (gains) on derivative instruments, net | 3,118 | (958) |
| Net cash provided by (used for) settlement of derivative instruments | (834) | 193 |
| Deferred taxes | (73) | 454 |
| Other, net | 47 | (1) |
| Changes in operating assets and liabilities: | ||
| Trade and other receivables | 41 | (29) |
| Inventory | (210) | 19 |
| Other non-current assets | 56 | (25) |
| Accounts payable and accrued liabilities | (213) | (789) |
| Total deferred revenue | (45) | (36) |
| Total operating lease liabilities | (282) | (307) |
| Other non-current liabilities | (216) | — |
| Other, net | (126) | (102) |
| Net cash provided by operating activities | 2,658 | 2,059 |
| Cash flows from investing activities | ||
| Property, plant and equipment, net of proceeds from commissioning sales of LNG of $85 million and $52 million, respectively | (1,916) | (1,647) |
| Proceeds from sale of equity method investment | — | 80 |
| Other, net | (11) | (8) |
| Net cash used in investing activities | (1,927) | (1,575) |
| Cash flows from financing activities | ||
| Proceeds from issuances of debt and borrowings | 4,511 | 265 |
| Redemptions and repayments of debt and borrowings | (3,263) | (565) |
| Distributions to NCI | (394) | (400) |
| Contributions from redeemable NCI | — | 49 |
| Redemption of redeemable NCI | (136) | — |
| Payments related to tax withholdings for share-based compensation | (37) | (46) |
| Repurchase of common stock, inclusive of excise taxes paid | (1,113) | (690) |
| Dividends to stockholders | (233) | (223) |
| Other, net | (128) | (43) |
| Net cash used in financing activities | (793) | (1,653) |
| Effect of exchange rate changes on cash, cash equivalents and restricted cash and cash equivalents | (3) | (4) |
| Net decrease in cash, cash equivalents and restricted cash and cash equivalents | (65) | (1,173) |
| Cash, cash equivalents and restricted cash and cash equivalents—beginning of period | 1,584 | 3,190 |
| Cash, cash equivalents and restricted cash and cash equivalents—end of period | 1,519 | 2,017 |
Amounts as printed on the EDGAR/iXBRL face — (in millions, except per share data); (in millions, except share data); (in millions). Labels, columns, and figures are the filing face, not a GAAP stencil. Interactive statements & notes on EDGAR ↗